Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Werner

Showing results (571-580 of 603) with videos related to

Pageof 61
Sort By:
Cancer Chemotherapy and Pharmacology|February 17, 2020
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumorsAnthony W Tolcher, Razelle Kurzrock, Vincente Valero, et al.
Placenta|July 28, 2009
Feto-placental adaptations to maternal obesity in the baboonD Farley, M E Tejero, A G Comuzzie, et al.
Frontiers in Immunology|December 30, 2022
Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locusPaola V Ferrero, Luisina I Onofrio, Cristina Del Valle Acosta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor MalignanciesPamela Munster, Rahul Aggarwal, David Hong, et al.
The Lancet. Oncology|September 3, 2019
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trialMansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J Birrer, et al.
Mucosal Immunology|January 28, 2016
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gelD Archary, K E Seaton, J S Passmore, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptorBrent W McCleland, Roderick S Davis, Michael R Palovich, et al.
Journal of the American College of Emergency Physicians Open|January 5, 2022
Overcoming barriers to promotion for women and underrepresented in medicine faculty in academic emergency medicineLaura Oh, Judith A Linden, Amy Zeidan, et al.
Resuscitation|February 4, 2010
Comparison of sudden cardiac arrest resuscitation performance data obtained from in-hospital incident chart review and in situ high-fidelity medical simulationLeo Kobayashi, David G Lindquist, Ilse M Jenouri, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Pageof 61

Showing results (571-580 of 603) with videos related to

Sort By:
Pageof 61
Cancer Chemotherapy and Pharmacology|February 17, 2020
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumorsAnthony W Tolcher, Razelle Kurzrock, Vincente Valero, et al.
Placenta|July 28, 2009
Feto-placental adaptations to maternal obesity in the baboonD Farley, M E Tejero, A G Comuzzie, et al.
Frontiers in Immunology|December 30, 2022
Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locusPaola V Ferrero, Luisina I Onofrio, Cristina Del Valle Acosta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor MalignanciesPamela Munster, Rahul Aggarwal, David Hong, et al.
The Lancet. Oncology|September 3, 2019
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trialMansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J Birrer, et al.
Mucosal Immunology|January 28, 2016
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gelD Archary, K E Seaton, J S Passmore, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptorBrent W McCleland, Roderick S Davis, Michael R Palovich, et al.
Journal of the American College of Emergency Physicians Open|January 5, 2022
Overcoming barriers to promotion for women and underrepresented in medicine faculty in academic emergency medicineLaura Oh, Judith A Linden, Amy Zeidan, et al.
Resuscitation|February 4, 2010
Comparison of sudden cardiac arrest resuscitation performance data obtained from in-hospital incident chart review and in situ high-fidelity medical simulationLeo Kobayashi, David G Lindquist, Ilse M Jenouri, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Pageof 61